Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRQ32K)

Drug Name
AX-024 Drug Info
Synonyms VMMKGVRPILDZML-UHFFFAOYSA-N; SCHEMBL903258; AKOS030622922; CS-8052; HY-107390; 1370544-73-2
Indication
Disease Entry ICD 11 Status REF
Multiple sclerosis 8A40 Phase 1 [1]
Cross-matching ID
PubChem CID
56949412
TTD Drug ID
DMRQ32K

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting T-cells (T-cells)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ATG-Fresenius S DM4VJ5Q Transplant rejection NE84 Phase 3 [2]
DiabeCell DMK6FYR Insulin-dependent diabetes 5A10 Phase 2 [3]
TVI-Kidney-1 DMGYSZ0 Renal cell carcinoma 2C90 Phase 2 [4]
Baltaleucel-T DM3WCL4 Diffuse large B-cell lymphoma 2A81 Phase 2 [5]
T2c-001 DM06GDC Congestive heart failure BD10 Phase 2 [3]
BPX-501 DMIMA4V Acute lymphoblastic leukaemia 2A85 Phase 1/2 [5]
RTL-1000 DM1B4CQ Multiple sclerosis 8A40 Phase 1 [6]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
NCK adaptor protein 1 (NCK1) TTMA3VF NCK1_HUMAN Modulator [1]
T-cells (T-cells) TTXQYT6 NOUNIPROTAC Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Neovii Biotech.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
4 Clinical pipeline report, company report or official report of TVAX Biomedical.
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 RTL THERAPY FOR MULTIPLE SCLEROSIS: A Phase I Clinical Study. J Neuroimmunol. 2011 February; 231(1-2): 7-14.